NIH-funded research R03 grant

How a specific protein affects mitochondria and gene expression

Official title: Impact of a Histone H3K9 Methyltransferase on Mitochondria

Funded at University of Delaware · NIH-11138957 · Data updated 2026-11-12

This study is looking at a protein called SETDB1 to see how it affects cell function and energy production, which could help us understand its role in diseases like leukemia, using tiny worms as a model.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Delaware
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJune 17, 2025
Project endMay 31, 2026
Funding year2025
Award (this year)$155,559
NIH project number1R03TR005626-01
Project IDNIH-11138957 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with acute myeloid leukemia or related rare diseases.

Less likely to help

Patients with conditions unrelated to the role of SETDB1 or mitochondrial dysfunction may not benefit from this research.

What this research studies

This research investigates the role of the histone methyltransferase SETDB1 in both the nucleus and cytoplasm, particularly its impact on mitochondria and gene expression. By studying a model organism, C. elegans, the researchers aim to understand how alterations in SETDB1 activity are linked to various diseases, including acute myeloid leukemia. The study employs advanced imaging techniques to visualize the localization and function of SETDB1 and its homolog MET-2, focusing on mitochondrial morphology and cellular responses to specific compounds. This approach could reveal new insights into the cellular mechanisms underlying these diseases.

Why it matters

Potential benefit: If successful, this research could lead to a better understanding of disease mechanisms and potential new therapeutic targets for conditions like acute myeloid leukemia.

How similar studies have gone: While the specific approach of this research is novel, similar studies have shown promising results in understanding the roles of histone modifications in disease.

Where this research is happening

  • University of Delaware
    Newark, United States
    Active

Researchers

  • Principal investigator: Tanis, Jessica E — University of Delaware
  • Study coordinator: Tanis, Jessica E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.